Holen Sie sich die Stockscreener-App
27.45
1.26%
-0.34
Harmony Biosciences Holdings Inc Aktie (HRMY) Neueste Nachrichten
Harmony Biosciences Reports 2025 Revenue Growth, Issues 2026 Outlook - MyChesCo
Harmony Biosciences Holdings, Inc. $HRMY Shares Acquired by American Century Companies Inc. - MarketBeat
Does Mixed Q4 Results and Reaffirmed WAKIX Guidance Change The Bull Case For Harmony Biosciences (HRMY)? - simplywall.st
Harmony Biosciences Eyes Blockbuster Future After Record Year - TipRanks
HRMY Technical Analysis & Stock Price Forecast - Intellectia AI
Harmony Biosciences to Participate in Upcoming Investor Conferences - Business Wire
Harmony Biosciences Holdings, Inc. (HRMY): Investor Outlook on Its Promising 45% Upside Potential - DirectorsTalk Interviews
HRMY Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
HC Wainwright Issues Pessimistic Forecast for HRMY Earnings - MarketBeat
Deutsche Bank Cuts PT on Harmony Biosciences Holdings (HRMY) to $30 From $31 - Bitget
Harmony Biosciences (NASDAQ:HRMY) Downgraded by Wall Street Zen to Hold - MarketBeat
A Look At Harmony Biosciences (HRMY) Valuation After Guidance Reaffirmation And New Pediatric WAKIX Approval - Sahm
MSN - MSN
Harmony Biosciences Downgrades Put Wakix Patent Risks In Sharp Focus - Yahoo Finance
HC Wainwright Issues Negative Estimate for HRMY Earnings - MarketBeat
Harmony Biosciences (NASDAQ:HRMY) Stock Rating Lowered by Zacks Research - MarketBeat
US applications for jobless aid rose modestly to 212,000 last week as layoffs remain at historically healthy levels - Bitget
Safe Bulkers, Inc. to Participate in the Dry Bulk Shipping Panel at the DNB Carnegie Energy & Shipping Conference in Oslo - Bitget
Truist Securities Downgrades Harmony Biosciences Holdings, Inc. (HRMY) to Hold After Patent Trial Developments - Yahoo Finance
Harmony Biosciences (HRMY) Is Down 20.1% After Reaffirming WAKIX Outlook and Winning Pediatric Approval - simplywall.st
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
20 Best Investments in 2026 - Insider Monkey
UBS Group Lowers Harmony Biosciences (NASDAQ:HRMY) Price Target to $36.00 - MarketBeat
Harmony Biosciences (HRMY): UBS Lowers Price Target to $36 | HRM - GuruFocus
HC Wainwright Reiterates Buy Rating for HRMY with $55 Target | H - GuruFocus
Harmony Biosciences' (HRMY) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
BEAM's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y - Finviz
RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up - Finviz
Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y - Finviz
Corcept's Q4 Earnings and Revenues Fall Short of Estimates - Finviz
Analysts Offer Insights on Healthcare Companies: ProQR (PRQR), Immunic (IMUX) and Harmony Biosciences Holdings (HRMY) - The Globe and Mail
UBS cuts Harmony Biosciences stock price target on earlier Wakix generic entry - Investing.com
Harmony Biosciences Holdings, Inc. Experiences Revision in Its Stock Evaluation Amid Market Volatility - Markets Mojo
Bank of America Lowers Harmony Biosciences (NASDAQ:HRMY) Price Target to $28.00 - MarketBeat
Needham & Company LLC Issues Pessimistic Forecast for Harmony Biosciences (NASDAQ:HRMY) Stock Price - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q4 2025 Earnings Call Transcript - Insider Monkey
Deutsche Bank Adjusts Harmony Biosciences PT to $30 From $31, Maintains Hold Rating - marketscreener.com
Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $36 at UBS - StreetInsider
CAVA Group To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga
B of A Securities Lowers Harmony Biosciences (HRMY) Price Target to $28 | HRMY Stock News - GuruFocus
Truist reiterates Hold on Harmony Biosciences stock, sets $25 target - Investing.com Australia
Harmony Biosciences price target lowered to $28 from $32 at BofA - TipRanks
Decoding Harmony Biosciences Holdings Inc (HRMY): A Strategic SW - GuruFocus
Harmony Biosciences (HRMY) Margin Compression In FY 2025 Tests Bullish Profitability Narrative - simplywall.st
Harmony Biosciences Holdings, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Harmony Biosciences Holdings Inc (HRMY) Q4 2025 Earnings Call Hi - GuruFocus
Harmony Biosciences Holdings, Inc. Reiterates Revenue Guidance for 2026 - marketscreener.com
Harmony Biosciences (HRMY) Reports Strong Q4 2025 Results, Eyes Blockbuster Revenue - GuruFocus
Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $28 at BofA Securities - StreetInsider
Truist reiterates Hold on Harmony Biosciences stock, sets $25 target By Investing.com - Investing.com Canada
Truist SecuritiesReinstates $25 target on Harmony Biosciences Holdings Inc. (HRMY) - StreetInsider
Harmony Biosciences Holdings (HRMY) Stock Analysis: Positioned for a 70% Upside in Biotech Sector - DirectorsTalk Interviews
Harmony Biosciences Hits Day Low at $26.03 Amid Price Pressure - Markets Mojo
Harmony Biosciences Holdings, Inc. Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo
Harmony Biosciences Q4 Earnings Call Highlights - MarketBeat
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):